Shanghai Pharma says bid for U.S. Cardinal Health’s China business

HONG KONG (Reuters) – Shanghai Pharmaceuticals Holding Co said it has bid for Cardinal Health Inc’s China business, as the U.S. drug distributor looks to exit over worries China’s upcoming drug distribution reform could slow its growth. Shanghai Pharma …
( read original story …)


Related Post